CISA has ordered government agencies to secure their systems against a high-severity Gogs vulnerability that was exploited in ...
CrowdStrike's 2025 data shows attackers breach AI systems in 51 seconds. Field CISOs reveal how inference security platforms ...
Microsoft is working on a redesigned Run dialog for Windows 11, but Raycast has just beaten the company with a much better ...
Sure! Here's the description with all links and additional text removed: Subscribe Twitter Facebook Shirts/Hats JFK's niece has message for man who bought Trump-Kennedy Center domain FBI releases ...
ATLANTA — A former executive with the Atlanta Housing Authority is accused of orchestrating an elaborate scheme that federal prosecutors say siphoned more than $200,000 in government funds for ...
Donald Trump mocked after seemingly confusing bald eagle with a falcon Hugh Jackman and Kate Hudson face backlash from real family behind tribute band film The Trump administration just ordered ...
Video game developer Vince Zampella, whose studios have created several of the world's best-selling games, was killed Sunday afternoon in a Ferrari crash on Southern California's Angeles Crest Highway ...
WASHINGTON – Former President Bill Clinton’s spokesperson called for the Justice Department to release all of its documents about the investigation of accused sex trafficker Jeffrey Epstein, to avoid ...
Vince Zampella, best known as the co-creator of the Call of Duty franchise and co-founder of Infinity Ward who went on to co-found Titanfall, Apex Legends, and Star Wars Jedi developer Respawn ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Section 1. Purpose and Policy. Americans deserve access to the best medical treatments and research infrastructure in the world. In 2023, the Food and Drug Administration (FDA) completed a review of ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...